Journal
NATURE MEDICINE
Volume 18, Issue 7, Pages 1028-1040Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nm.2807
Keywords
-
Funding
- US National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Pfizer
- MedImmune
- Amgen
- Regeneron
- Centocor
- Genentech
Ask authors/readers for more resources
Fibrosis is a pathological feature of most chronic inflammatory diseases. Fibrosis, or scarring, is defined by the accumulation of excess extracellular matrix components. If highly progressive, the fibrotic process eventually leads to organ malfunction and death. Fibrosis affects nearly every tissue in the body. Here we discuss how key components of the innate and adaptive immune response contribute to the pathogenesis of fibrosis. We also describe how cell-intrinsic changes in important structural cells can perpetuate the fibrotic response by regulating the differentiation, recruitment, proliferation and activation of extracellular matrix-producing myofibroblasts. Finally, we highlight some of the key mechanisms and pathways of fibrosis that are being targeted as potential therapies for a variety of important human diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available